---
title: "Asian-specific versus global BMI thresholds alter overweight and obesity surveillance in India, Ba"
id: "plos-one-10-national-macro-surveillance-of-overweight-and-obesity-in-india-bangladesh-and"
canonical_url: "https://medichelpline.com/clinical-feed/plos-one-10-national-macro-surveillance-of-overweight-and-obesity-in-india-bangladesh-and"
content_type: "clinical_feed_article"
specialty: "Endocrinology"
source_name: "PLOS ONE (Medicine)"
source_url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0363136"
published_at: "2026-11-18T14:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Asian-specific versus global BMI thresholds alter overweight and obesity surveillance in India, Ba
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/plos-one-10-national-macro-surveillance-of-overweight-and-obesity-in-india-bangladesh-and
- **Specialty:** [Endocrinology](https://medichelpline.com/clinical-feed/endocrinology.md)
- **Primary Source:** PLOS ONE (Medicine)
- **Source URL:** [Original Journal Publication](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0363136)
- **Published At:** 2026-11-18T14:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The review synthesized peer-reviewed studies (2015–May 2026) that used nationally representative, multi-stage surveys (DHS, NFHS, MICS, WHO-STEPS) to report population-level **overweight and obesity** prevalence across India, Bangladesh, and Nepal. - Investigators compared prevalence estimates derived from the global **BMI** cutoff (≥25 kg/m2) with Asian-specific thresholds (≥23 kg/m2) to quantify diagnostic impact on national surveillance. - Applying the Asian-specific cutoff produced a marked increase in reported OWOB prevalence; in reproductive-aged Bangladeshi women the pooled prevalence more than doubled, reaching 55.3% under the Asian-specific criterion (reported range and dates are drawn from the source). - The most consistent associated factors formed a dominant wealth–urbanization cluster: higher household wealth, higher education, and urban residence correlated with increased OWOB across the three countries. - Obstetric correlates were repeatedly observed: higher parity and history of cesarean delivery associated with greater OWOB prevalence in national samples. - Direct measures of diet and physical activity were rarely reported; the literature largely relied on demographic and asset proxies, creating what the authors call an asset-association loop. - The review followed PRISMA 2020 procedures and was registered with PROSPERO (CRD420261408604); searches included PubMed, Scopus, Web of Science, DOAJ, Google Scholar, and IMSEAR. - Authors argue that continued reliance on global **BMI** cutoffs conceals the South Asian overnutrition burden and recommend national reporting adopt Asian-specific thresholds and incorporate validated behavioral metrics into surveys. - Key methodological heterogeneity remained: surveys differed in sampled subpopulations (e.g., all reproductive-age women vs ever-married women) and some studies applied different BMI standards, which can skew pooled estimates and trend interpretation. - The review identifies clear surveillance gaps and calls for harmonized national reporting and direct dietary/physical activity measurement to guide public health action.
## Clinical Analysis & Structured Key Points
National macro-surveillance of overweight and obesity in India, Bangladesh, and Nepal: A systematic review of global versus Asian BMI thresholds and associated factors | PLOS One Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click here . Article Authors Metrics Comments Media Coverage Peer Review Reader Comments Figures Figures Abstract Introduction Evaluating how global versus Asian-specific body mass index (BMI) thresholds impact macro-level population surveillance is essential for addressing South Asia’s changing epidemiological landscape. We systematically synthesized the prevalence of overweight and obesity and identified significant associated factors across India, Bangladesh, and Nepal to compare the diagnostic impact of these distinct BMI criteria. Materials and methods Following PRISMA guidelines, we searched electronic databases including PubMed, Scopus, Web of Science, Directory of Open Access Journals (DOAJ), Google Scholar, and Index Medicus for the South-East Asia Region (IMSEAR) for peer-reviewed studies published between 2015 and 2026 utilizing nationally representative datasets from 2011 onward. Overlapping surveys were grouped into cohort families to prevent duplicate counting. Studies were stratified by BMI criteria and demographic subgroups. Results Shifting from global (≥25 kg/m 2 ) to Asian-specific (≥23 kg/m 2 ) BMI cutoffs triggered a substantial prevalence jump in reported overweight and obesity outcomes. Between 2011 and 2022, overweight and obesity prevalence among reproductive-aged Bangladeshi women more than doubled, reaching 55.3% under the Asian-specific threshold. Significant associated factors mapping revealed a dominant wealth-urbanization cluster (higher household wealth, higher education, and urban residency) and significant obstetric factors (higher parity and cesarean delivery) across all three nations. Crucially, direct dietary intake and physical activity metrics were virtually unmeasured, trapping regional literature in an asset-association loop. Conclusions Relying on global BMI criteria severely masks the South Asian overnutrition crisis and delays vital public health interventions. National health agencies must integrate localized, Asian-specific BMI cutoffs into regional reporting frameworks and shift surveillance focus from simple demographic asset proxies toward direct, validated dietary and behavioral metrics. Citation: Parajuli R, Oldewage-Theron W, Niraula SR (2026) National macro-surveillance of overweight and obesity in India, Bangladesh, and Nepal: A systematic review of global versus Asian BMI thresholds and associated factors. PLoS One 21(11): e0363136. https://doi.org/10.1371/journal.pone.0363136 Editor: George Kuryan, Christian Medical College, INDIA Received: July 25, 2026; Accepted: November 3, 2026; Published: November 18, 2026 Copyright: © 2026 Parajuli et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability: All relevant data are within the manuscript and its Supporting Information files. Funding: The author(s) received no specific funding for this work. Competing interests: The authors have declared that no competing interests exist. 1 Introduction While India, Bangladesh, and Nepal account for approximately 79% of the South Asian population [ 1 ] and 56% of the region’s landmass [ 2 ], this demographic is currently facing a public health threat from the increasing incidence ofoverweight and obesity (OWOB). Clinically defined as body mass exceeding standard height parameters and abnormal adipose accumulation that threatens systemic health [ 3 , 4 ], OWOB is now recognized as a critical global health epidemic. World Health Organization (WHO) estimates show the global burden has expanded from 1.9 billion overweight and 650 million obese adults in 2016 [ 5 ] to 2.5 billion and 890 million recently [ 6 ], with projections approaching one billion obese individuals by 2030 [ 7 ]. Once viewed as unique to wealthy Western nations [ 8 ], this epidemic is rapidly transitioning to developing regions. This shift is starkly apparent in South Asia, where the acceleration of OWOB outpaces developed nations by 30% [ 9 ], a trajectory driven by rapid macroeconomic transitions and gross domestic product growth [ 10 ]. An extensive body of clinical literature has firmly established that excessive adiposity drives a multitude of metabolic comorbidities while significantly escalating both cause-specific and all-cause mortality rates [ 11 ]. This was highlighted by a large-scale systematic review and meta-analysis of 97 prospective cohort studies, encompassing more than 2.88 million subjects and over 270,000 recorded fatalities, which revealed a significantly increased risk of mortality among overweight and obese cohorts compared to individuals maintaining a normal weight range [ 12 ]. Pathophysiologically, obesity stems from an intricate interplay between intrinsic genetic susceptibility and external environmental determinants. Data from twin and sibling cohorts suggest that genetic heritage influence between 50% and 90% of individual variations in Body Mass Index (BMI). Specifically, it is estimated that heritability account for 60% to 70% of the variance in BMI, whereas shared familial environments account for 25% and unique individual factors contribute to the remaining 14% [ 13 ]. Importantly, South Asian populations present a unique physiological vulnerability. Bajaj and co-authors (2024) [ 14 ] and Mehta (2025) [ 15 ] found that South Asians exhibit a distinct biological predisposition characterized by a “high body fat, low muscle mass, and high visceral adiposity” phenotype frequently referred to the South Asian “thin-fat” phenotype. Consequently, metabolic disturbances, insulin resistance, and cardiovascular diseases manifest at significantly lower BMI thresholds in this population compared to Western cohorts [ 14 , 15 ]. This physiological divergence has prompted a controversial debate regarding diagnostic standards within South Asian epidemiological literature. Across various surveyed South Asian populations, adult OWOB rates currently vary considerably between 22.4% and 52.4%, contrasting with a lower prevalence of 1.3% to 7.6% observed among pediatric cohorts [ 16 ]. A broader regional analysis calculated a pooled OWOB prevalence of 19.3% among South Asian children and adolescents, reaching a country-specific estimate of 13.6% in Bangladesh and 10.1% in Nepal [ 17 ]. Crucially, relying on Global WHO standards rather than localized Asian thresholds fail to capture the true public health burden, delaying early screening and lifestyle interventions for millions of individuals during their reproductive and productive years. The convergence of fast-paced macroeconomic growth, structural urbanization, and clinically significant lifestyle changes has created an environment that potentiates underlying genetic vulnerabilities, resulting in rising obesity rates across both adult and pediatric generations [ 18 ]. While localized, field-based studies offer beneficial community-specific snapshots, whilst frequently introducing selection, institutional, and geographic biases that distort the macro-epidemiological picture. To design actionable, state-level interventions, public health authorities require data derived from macro-level evidence. Over the last decade, peer-reviewed literature has relied heavily on secondary analyses of multi-stage, stratified, nationally representative probability surveys such as the Demographic and Health Surveys (DHS), National Family Health Surveys (NFHS), and Multiple Indicator Cluster Surveys (MICS) to document these population-level trends. However, the diverse sampling methodologies of these national data registries (e.g., surveying all reproductive-age women versus restricting cohorts to ever-married women) and the inconsistent application of standard versus localized BMI thresholds require a rigorous, harmonized synthesis to prevent mathematical skew and misinterpretation. Therefore, this systematic review that is focusing on India, Bangladesh, and Nepal, is essential to synthesize peer-reviewed literature utilizing nationally representative datasets. By evaluating population-level prevalence trends across conflicting diagnostic standards and providing an evidence-mapped analysis of the socio-demographic, economic, obstetric, and geographic associated factors, this study aims to provide robust, region-specific evidence needed to facilitate effective macro-level public health frameworks, preventive strategies, and structural policy interventions across the South Asian subcontinent. 2 Materials and methods 2.1 Study design This systematic review was designed and executed in strict adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement [ 19 ]. The systematic review is registered with the International Prospective Register of Systematic Reviews (PROSPERO) with the registration ID: CRD420261408604. Methodologically, this study relies on a rigorous, secondary desk-based framework to aggregate and synthesize peer-reviewed literature regarding the epidemiology of overweight and obesity across India, Bangladesh, and Nepal. To build an analysis that is both regionally relevant and contextually representative, the literature retrieval system combined major global citation networks like PubMed, Scopus, Web of Science, Directory of Open Access Journal (DOAJ), and Google Scholar with targeted regional data repositories, most notably the Index Medicus for the South-East Asia Region (IMSEAR). This integrated search strategy was deliberately chosen to capture highly relevant, population-level literature that frequently remains unindexed within broader international bibliographic databases. The comprehensive, item-by-item PRISMA documentation is provided in S1 File . 2.2 Eligibility criteria Studies were eligible for inclusion if they satisfied the following parameters: Peer-reviewed literatures whose data source is a nationally representative, multi-stage stratified cluster survey (e.g., papers utilizing data from the Demographic and Health Surveys (DHS), Multiple Indicator Cluster Surveys (MICS), WHO-STEPS, or National Family Health Surveys (NFHS) to ensure standardized anthropometric protocols, robust statistical power, and authentic national coverage. Published between January 2015, and May 2026. Literature reporting prevalence within the national boundaries of Bangladesh, India, or Nepal, and quantitative reporting of prevalence outcome for overweight and obesity (OWOB). To maintain a high-fidelity synthesis and minimize data redundancy, few exclusion criteria were applied: Explicitly exclude any published papers using localized primary data (institutional, municipal, state-specific convenience, or primary cross-sectional field data) to ensure maximum generalizability and eliminate the profound urban and institutional biases inherent to localized studies. Research published prior to 2015 was excluded to ensure the findings reflect the most recent comparison between the three nations. Multi-national or regional studies were excluded if specific, extractable prevalence data for the three target countries (Bangladesh, India, or Nepal) were not provided. Exclusion based on incomplete or aggregated outcome data reporting associated with heterogeneous study populations. Literature utilizing the dataset before 2011 to report the outcome (overweight and obesity) were excluded to ensure the findings reflect the contemporary landscape of over nutrition and the comparison across the nations. Studies with fatal reporting contradictions and missing sample sizes were also excluded. Systematic reviews, meta-analyses, case reports, editorials, and commentaries were excluded. 2.3 Search strategy A comprehensive literature search was conducted to identify peer-reviewed articles reporting on nationally representative data and associated factors of overweight and obesity in three South Asian countries between 2015 and 2026. Records were retrieved from PubMed, Google Scholar, DOAJ, IMSEAR, Scopus, and Web of Science using a combination of controlled vocabulary (e.g., MeSH terms in PubMed like “Overweight,” “Obesity,” “Body Mass Index,” “Prevalence”) and specific text-word keywords. To isolate macro-surveillance data and exclude localized primary studies, the search strategy explicitly integrated terms for established survey frameworks, including “Demographic and Health Survey” (DHS), “National Family Health Survey” (NFHS), “Multiple Indicator Cluster Survey” (MICS), “STEPS survey,” and descriptors such as “nationally representative,” and “national survey.” These were combined with specific country names – India, Bangladesh, and Nepal, using Boolean operators “AND” and “OR” to unite the concepts. Search limits were restricted to human studies and the specified publication years. Eligibility criteria were strictly assessed during screening. PubMed Search String: ((“Overweight”[MeSH] OR “Obesity”[MeSH] OR “Body Mass Index”[MeSH] OR overweight[tiab] OR obesity[tiab] OR obese[tiab] OR BMI[tiab]) AND (“Prevalence”[MeSH] OR prevalence[tiab] OR epidemiology[Subheading] OR burden[tiab] OR determinants[tiab]) AND (“South Asia”[MeSH] OR Bangladesh[tiab] OR India[tiab] OR Nepal[tiab]) AND (“Demographic and Health Survey”[tiab] OR DHS[tiab] OR “National Family Health Survey”[tiab] OR NFHS[tiab] OR “Multiple Indicator Cluster Survey”[tiab] OR MICS[tiab] OR “STEPS survey”[tiab] OR “nationally representative”[tiab] OR “national survey”[tiab])) Limits: Humans, Publication year (2015–2026), Journal Articles All searches were performed systematically, and the search strategy for each database is presented in details in the S2 File . All searches were run independently by two authors. The articles were finalized to include in the study after a discussion and reaching consensus based on the eligibility criteria. 2.4 Gathering and compilation of literature Authors used Zotero reference management software (version 7.0; available from: https://www.zotero.org ) for the arrangement, compilation, deduplication, screening of title and abstract of the literature. 2.5 Risk of bias assessment The methodological quality of the included studies was assessed using Joanna Briggs Institute (JBI) critical appraisal tool [ 20 ]. The Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Analytical Cross-Sectional Studies was selected as the optimal quality assessment tool for this review, given that the included literature exclusively evaluates data from inherently cross-sectional national surveillance registries. In strict accordance with JBI guidelines, each of the eight methodological domains was evaluated and scored as “Yes,” “No,” “Unclear,” or “Not Applicable.” These domains comprehensively look for the following eight domains: The clarity of sample inclusion criteria The depth of description regarding study subjects and settings The validity and reliability of exposure measurements The utilization of objective, standardized criteria to measure the target condition The precise identification of confounding variables The implementation of specific strategies to mitigate confounding The validity and reliability of outcome measurements and The appropriateness of the applied statistical models. Because the JBI framework is designed primarily for qualitative appraisal rather than rigid quantitative scoring, it does not recommend using a strict numerical index to grade study quality. Instead, included studies were stratified into low, moderate, or high risk of bias based on their adherence to these core methodological domains. Categorization as Low Risk (High Quality), Moderate Risk, or High Risk (Low Quality) was done particularly focusing on critical domains like confounding (Q5, Q6) and measurement validity (Q3, Q4, Q7). High Risk: Assigned to publications exhibiting inadequate descriptions of target participants or unclear methods regarding the control of confounding variables. Moderate Risk: Assigned to literature that satisfied most core criteria but relied on sub-optimal features, such as limited sample sizes or localized convenience frameworks, that potentially constrain population generalizability. Low Risk: Reserved for studies demonstrating exceptional methodological rigor, characterized by the utilization of highly validated exposure measurement tools and sophisticated statistical adjustments for confounding factors. The appraisal process was executed independently by two authors, with any discrepancies resolved through targeted discussion and reaching the consensus. Risk of bias evaluations were not utilized as an exclusion threshold; instead, they directly informed the interpretation of our synthesized findings. The complete, item-by-item critical appraisal matrix is provided in Excel format as S3 File . 2.6 Data extraction For each included study, the following information was collected: Study (Author and Date), Data Source, Study Design, Sample Population Size, Gender and Age, OWOB Prevalence (%), BMI Cut-off Used (Global or Asian), and Significant Associated Factors. Data were extracted independently by two authors. Extracted data were cross-checked for accuracy prior to synthesis. 2.7 Data synthesis and analysis To account for variations in clinical definitions and ensure data comparability across countries, studies were stratified into subgroups based on the specific body mass index (BMI) cutoff points utilized by the authors (Global WHO criteria versus Asian-specific criteria). This stratification served as the primary structural framework for both prevalence mapping and the narrative synthesis of associated factors. Because primary datasets exhibited substantial methodological heterogeneity, particularly in non-harmonized adult age floors (15 years and above, 18 years and above, 25 years and above, or 35 years and above) and disparate participant exclusion protocols across survey waves, a quantitative meta-analysis was precluded. Consequently, data synthesis was executed in strict accordance with the Synthesis Without Meta-Analysis (SWiM) reporting guidelines. For cross-country comparison, overlapping survey waves within the same population group were organized into cohort families. To prevent artificial denominator expansion, a hierarchical selection protocol was applied: the survey with the higher sample size was prioritized; in cases of negligible sample size differences, the most recent survey wave was selected. Furthermore, to ensure methodological equivalence, cross-country comparisons were strictly stratified by diagnostic criteria, utilizing dedicated comparative frameworks for Asian-specific cut-offs and Global cut-offs. Narrative synthesis focused on comparing standardized outcome measures across subgroups, while significant associated factors were synthesized on the basis of p value less than 0.05 (p < 0.05). 3 Results 3.1 Literature retrieval and geographic distribution The systematic search across global and regional bibliographic networks initially yielded a total of 1,185 records. Following the elimination of duplicate entries and the execution of a rigorous screening protocol encompassing sequential title, abstract, and full-text eligibility assessments, 31 original research articles satisfied all criteria and were retained for the final synthesis. The selected literature provides a robust epidemiological cross-section of the three target nations. Among the finalized studies, the highest volume originated from Bangladesh (n = 14), followed by Nepal (n = 9) and India (n = 8). This institutional distribution provides an
## Related Clinical Research

- [Amylyx Presents Avexitide Results; MiniMed Launches Tubeless Insulin Pump](https://medichelpline.com/clinical-feed/endocrine-news-0-pharma-friday-november-21-2026.md)
- [Advances in Diabetes Technology: Digital Platforms Beyond Continuous Glucose Monitoring](https://medichelpline.com/clinical-feed/endocrine-news-0-beyond-the-sensor-enhancing-diabetes-technology.md)
- [Myeloid mDIC (SLC25A10) Loss Reprograms Adipose Macrophages and Improves Metabolism in Obesity](https://medichelpline.com/clinical-feed/biorxiv-11-myeloid-mdic-deficiency-remodels-adipose-macrophages-to-an-efferocytosis.md)
- [Later bedtimes and late eating tied to higher metabolic syndrome risk](https://medichelpline.com/clinical-feed/medical-news-today-0-eating-and-sleeping-later-associated-with-increased-health-risks.md)
- [Genomic SEM identifies shared genetic architecture and candidate genes for insulin resistance–rela](https://medichelpline.com/clinical-feed/plos-one-18-integrative-genomic-sem-analysis-of-shared-genetic-architecture-and-candidate.md)

## Navigation
- [← Back to Endocrinology Feed](https://medichelpline.com/clinical-feed/endocrinology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.